Inactive Instrument
TetraLogic Pharmaceuticals Corporation Share Price Other OTC
Stocks
TLOG
US88165U1097
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 1.52M 1.32M 1.23M 1.13M 2.13M 145M 2.16M 14.47M 5.68M 72.1M 5.7M 5.57M 242M | P/E 2014 |
-2.96x | P/E 2015 | -0.82x |
|---|---|---|---|---|---|
| Enterprise Value | 9.44M 8.21M 7.64M 7.01M 13.25M 901M 13.45M 90.05M 35.34M 449M 35.46M 34.68M 1.5B | EV / Sales 2014 |
-
| EV / Sales 2015 | - |
| Free-Float |
100% | Yield 2014 * |
-
| Yield 2015 | - |
| 1 day | -17.65% |
| Manager | Title | Age | Since |
|---|---|---|---|
Jonathan Barie
PSD | President | - | - |
| Director of Finance/CFO | 68 | 29/04/2016 | |
Richard Sherman
LAW | General Counsel | 78 | 31/10/2012 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -17.65% | -17.65% | - | - | 972 | |
| +2.35% | +2.74% | +38.10% | +71.29% | 56.54B | |
| -0.21% | -7.38% | +27.52% | +61.15% | 53.6B | |
| -2.44% | +1.40% | -15.61% | -15.45% | 22.91B | |
| -2.85% | -7.78% | -9.28% | +345.55% | 21.37B | |
| +2.49% | -0.92% | +23.57% | -13.14% | 20.27B | |
| +0.79% | -1.06% | +33.99% | -31.95% | 17.56B | |
| +0.58% | -5.88% | +19.40% | +527.50% | 14.75B | |
| +3.41% | -6.61% | +162.81% | +278.22% | 13.53B | |
| -5.25% | -4.23% | +42.32% | +170.15% | 13.33B | |
| Average | -1.88% | -3.79% | +35.87% | +154.81% | 25.98B | |
| Weighted average by Cap. | +0.23% | -2.96% | +30.79% | +116.84% |
| 2014 | 2015 | |
|---|---|---|
| Net sales | - | - |
| Net income | -35.96M -31.26M -29.1M -26.71M -50.45M -3.43B -51.23M -343M -135M -1.71B -135M -132M -5.73B | -49.72M -43.23M -40.23M -36.94M -69.76M -4.75B -70.84M -474M -186M -2.36B -187M -183M -7.92B |
| Net Debt | -22.32M -19.4M -18.06M -16.58M -31.31M -2.13B -31.79M -213M -83.54M -1.06B -83.82M -81.98M -3.56B | 7.92M 6.89M 6.41M 5.89M 11.12M 757M 11.29M 75.58M 29.66M 377M 29.76M 29.11M 1.26B |
Employees
-
